Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Antiretroviral therapy for HIV-associated nephropathy
4 evidence topics · 4 sources
Antiretroviral therapy recommendation: KDIGO 2021 glomerular diseases guideline
Antiretroviral therapy and HIVAN: KDIGO Controversies Conference on kidney disease in HIV
“The classic kidney disease of HIV infection, HIV-associated nephropathy (HIVAN), has become less common with widespread use of antiretroviral therapy (ART); however, there has been a simultaneous increase in the prevalence of other kidney diseases.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Evidence from observational studies strongly supports the beneficial effect of early ART initiation on the risk of classic HIVAN.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Given the overwhelming benefit on survival, ART is recommended for all HIV-positive individuals.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote